日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

A Phase I Dose-Escalation Study of the HIF-2 Alpha Inhibitor DFF332 in Patients with Advanced Clear-Cell Renal Cell Carcinoma

一项针对晚期透明细胞肾细胞癌患者的 HIF-2α 抑制剂 DFF332 的 I 期剂量递增研究

期刊:Clinical Cancer Research
影响因子:10.2
doi:10.1158/1078-0432.CCR-24-2618
Pal, Sumanta K; Bernard-Tessier, Alice; Grell, Peter; Gao, Xin; Kotecha, Ritesh R; Picus, Joel; de Braud, Filippo; Takahashi, Shunji; Wong, Alvin; Suárez, Cristina; Otero, Javier A; Kundamal, Nicole; Yang, Xin; Sharaby, Sherif; Roy, Mike; Barzaghi-Rinaudo, Patrizia; Tannir, Nizar M
肿瘤
肾癌
肿瘤免疫
细胞生物学
发表日期：2025
文献求助 收藏

Reciprocal stabilization of coagulation factor XIII-A and -B subunits is a determinant of plasma FXIII concentration

凝血因子 XIII-A 和 -B 亚基的相互稳定作用是血浆 FXIII 浓度的决定因素。

期刊:Blood
影响因子:23.1
doi:10.1182/blood.2023022042
Byrnes, James R; Lee, Taek; Sharaby, Sherif; Campbell, Robert A; Dobson, Dre'Von A; Holle, Lori A; Luo, Michelle; Kangro, Kadri; Homeister, Jonathon W; Aleman, Maria M; Luyendyk, James P; Kerlin, Bryce A; Dumond, Julie B; Wolberg, Alisa S
发表日期：2024
文献求助 收藏

QSP modeling of a transiently inactivating antibody-drug conjugate highlights benefit of short antibody half life.

对瞬时失活抗体-药物偶联物的 QSP 建模突显了抗体半衰期短的优势

期刊:Journal of Pharmacokinetics and Pharmacodynamics
影响因子:2.8
doi:10.1007/s10928-024-09956-1
Khera Eshita, Dharmarajan Lekshmi, Hainzl Dominik, Engelhardt Volker, Vostiarova Helena, Davis John, Ebel Nicolas, Wuersch Kuno, Romanet Vincent, Sharaby Sherif, Kearns Jeffrey D
免疫/内分泌
发表日期：2024
文献求助 收藏

Intravenous versus Oral Acetaminophen for Pain: Systematic Review of Current Evidence to Support Clinical Decision-Making

静脉注射与口服对乙酰氨基酚镇痛：支持临床决策的现有证据系统评价

期刊:
影响因子:
doi:10.4212/cjhp.v68i3.1458
Jibril, Farah; Sharaby, Sherif; Mohamed, Ahmed; Wilby, Kyle J
发表日期：2015
文献求助 收藏